Analytical Data
-
Gene name
Ba71V-93
- Application
-
Alternative Names
Phosphoprotein p32 (p32)
-
Species
African swine fever virus
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P34204
-
Expression Region
1-204aa
-
Molecular Weight
27.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The Ba71V-93 recombinant protein is derived from the Ba71V strain of the avian reovirus, a virus known to infect poultry and cause various health issues in birds, including respiratory and enteric diseases. The study of Ba71V-93 focuses on understanding its structure and function, as well as its potential implications in vaccine development and disease management in avian populations. Researchers are particularly interested in the protein's role in eliciting immune responses, as it may serve as a candidate for subunit vaccines that could provide a safer alternative to live attenuated vaccines. Additionally, characterizing Ba71V-93 can enhance our understanding of viral pathogenesis and molecular interactions between the virus and host immune systems. The insights gained from this research not only aim to improve poultry health and productivity but also contribute to the broader field of virology and immunology, offering potential applications in both veterinary medicine and public health due to the zoonotic potential of various avian pathogens. As the global demand for poultry products increases, tackling reovirus infections through advanced biotechnological approaches like recombinant protein research becomes imperative, highlighting the importance of Ba71V-93 as a focal point for future studies.
